story of the week
Lenvatinib Plus Letrozole in Postmenopausal Women With Hormone Receptor–Positive Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase Ib/II dose expansion study of lenvatinib combined with letrozole in post-menopausal women with hormone receptor positive breast cancer
Clin. Cancer Res 2022 Apr 01;[EPub Ahead of Print], JSJ Lim, ALA Wong, SGW Ow, NYL Ngoi, GHJ Chan, YLE Ang, WQ Chong, SE Lim, YW Lim, M Lee, JRE Choo, HL Tan, WP Yong, RA Soo, DSP Tan, CE Chee, R Sundar, K Yadav, S Jain, L Wang, BC Tai, BC Goh, SC LeeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.